1 year return (CAGR)
494.00%
Sellas Life Sciences Group Inc Exchange (NASDAQ, USD)
SLS
10.15
-0.53 (-4.27%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
102.53%
5 year return (CAGR)
7.08%
10 year return (CAGR)
-48.82%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
2.40B
Price/Sales
-
Ent value
2.27B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 12.19 |
| Daily high | 12.44 |
| Daily low | 11.71 |
| Daily Volume | 4.70M |
| All-time high | 335364.00 |
| 1y analyst estimate | 32.50 |
| Beta | 2.52 |
| EPS (TTM) | -0.17 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 13 Mar 2026 |
Downside potential
Loading...
Downside potential data
| SLS | S&P500 | |
| Current price drop from All-time high | -100.00% | -1.25% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 20 Feb 2024 | 9 Mar 2009 |
| Avg drop from high | -89.63% | -10.65% |
| Avg time to new high | 2339 days | 12 days |
| Max time to new high | 4677 days | 1805 days |
News
